Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Nayoung Ryoo"'
Autor:
Danyeong Kim, Nayoung Ryoo, Young Ho Park, Eva Bagyinszky, Seong Soo Alexander An, SangYun Kim
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 12, Pp 9917-9925 (2023)
Autosomal recessive spastic ataxia in Charlevoix-Saguenay (ARSACS) is a neurodegenerative disorder caused by mutations in the sacsin molecular chaperone protein (SACS) gene. Since the first report from Quebec in 1978, many pathogenic ARSACS variants
Externí odkaz:
https://doaj.org/article/add939dc022f41ebae9f99774977e872
Autor:
Young Chul Youn, Hye Ryoun Kim, Hae-Won Shin, Hae-Bong Jeong, Sang-Won Han, Jung-Min Pyun, Nayoung Ryoo, Young Ho Park, SangYun Kim
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background The tendency of amyloid-β to form oligomers in the blood as measured with Multimer Detection System-Oligomeric Amyloid-β (MDS-OAβ) is a valuable biomarker for Alzheimer’s disease and has been verified with heparin-based plasm
Externí odkaz:
https://doaj.org/article/2fe9a1f3d19646abb896e9de78160179
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-7 (2021)
Abstract Background Cholinesterase inhibitors (ChEIs) are an FDA-approved symptomatic treatment for patients with Alzheimer’s disease (AD). Its efficacy in patients with mild cognitive impairment (MCI), however, is controversial. Nonetheless, ChEIs
Externí odkaz:
https://doaj.org/article/a32958fc7f2f4fe8aae8a6c20717b465
Autor:
Kyu Hwan Shim, Min Ju Kang, Jee Won Suh, Jung-Min Pyun, Nayoung Ryoo, Young Ho Park, Young Chul Youn, Jae-Won Jang, Jee Hyang Jeong, Kyung Won Park, Seong Hye Choi, Kyoungho Suk, Ho-Won Lee, Pan-Woo Ko, Chan-Nyoung Lee, Tae-Sung Lim, Seong Soo A. An, SangYun Kim, for the Alzheimer’s Disease All Markers (ADAM) Research group
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-12 (2020)
Abstract Background Recently, several studies suggested potential involvements of α-synuclein in Alzheimer’s disease (AD) pathophysiology. Higher concentrations of α-synuclein were reported in cerebrospinal fluid (CSF) of AD patients with a posit
Externí odkaz:
https://doaj.org/article/e3d7a8adebbf4a8dbe28284000ac5a23
Autor:
Yun Jung Bae, Jong-Min Kim, Byung Se Choi, Nayoung Ryoo, Yoo Sung Song, Yoonho Nam, In-Young Yoon, Se Jin Cho, Jae Hyoung Kim
Publikováno v:
Radiology.
Autor:
Seong Soo A. An, Sungmin Kang, Nayoung Ryoo, SangYun Kim, Ji Sun Ryu, Young Chul Youn, Kyu Hawn Shim, Jung Min Pyun, Young Ho Park, Sang Won Han, Ryan Lee
Publikováno v:
Clinical Interventions in Aging
Jung-Min Pyun,1 Ji Sun Ryu,2 Ryan Lee,2 Kyu Hawn Shim,3 Young Chul Youn,4 Nayoung Ryoo,5 Sang-Won Han,5 Young Ho Park,5 Sungmin Kang,2 Seong Soo A An,6 SangYun Kim5 1Department of Neurology, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu
Autor:
Jung-Min Pyun, Nayoung Ryoo, Jeewon Suh, Young Chul Youn, SangYun Kim, Min Ju Kang, Young Ho Park
Publikováno v:
Journal of Alzheimer's Disease. 75:685-696
Amyloid-β (Aβ) is a key protein in Alzheimer's disease (AD) in that its accumulation induces complex pathological changes. Although there has been extensive research on the metabolism of Aβ in AD, new compelling results have recently emerged. Hist
Publikováno v:
Dement Geriatr Cogn Disord
Background: Fibrinogen is considered a marker of vascular pathology, indicating a weakened blood-brain barrier, and has a causative role in neuroinflammation and neurodegeneration. Little is known about the relationship between fibrinogen levels and
Publikováno v:
Alzheimer's & Dementia. 17
Publikováno v:
Acta Neurologica Belgica. 122:249-250